Lv11
40 积分 2024-07-04 加入
Metabolic Dysfunction–Associated Steatotic Liver Disease
5天前
已完结
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
5天前
已完结
Glycogen Synthase Kinase 3 β Hepatocyte Deletion Attenuates Ferroptosis and Metabolic Dysfunction-Associated Steatohepatitis in Mice
6天前
已完结
Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction
4个月前
已关闭
Sappanone A alleviates metabolic dysfunction-associated steatohepatitis by decreasing hepatocyte lipotoxicity via targeting Mup3 in mice
7个月前
已完结
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients
10个月前
已完结
Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease
10个月前
已完结
Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway
10个月前
已完结
Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1
10个月前
已完结
Role of exosome-derived miRNAs in diabetic wound angiogenesis
11个月前
已完结
皖公网安备34019202002308
